FDA Approves Strattera For ADHD Treatment

“This is critical as ADHD may be a life-long disease and effective long-term control of symptoms may mean improved outcomes in children and adolescents.”

Eli Lilly and Company announced that FDA has approved Strattera for maintenance treatment of Attention-Deficit/Hyperactivity Disorder in children and adolescents. via EMaxHealth

Leave a Comment

Posted by roboblogger

Full Story: EMaxHealth

Related Topix

Business - Biotech, Eli Lilly, Healthcare Industry
Places - Allen, MD
Health - Medicine
Life - Healthcare Law, Law

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Allen Discussions

Topic	Updated	Last By	Comments
Ruark to appear in court Monday for DUI	21 hr	lastword	4
Suspect sought in city's first murder	21 hr	lastword	3
Worst not over, governor warns	Fri	Penman	22
Poll: Do blacks commit more crimes than other races	May 9	lastword	17
Ruth Callahan Westfall	May 7	lastword	3
Residents, like IRS, can expect checks in mail	May 5	Joe	1
Poll: Too many dope dealers in Salisbury area.	May 5	lastword	4

FDA Approves Strattera For ADHD Treatment

Allen News

Allen Conditions

Weather

Allen Yellow Pages

Most Popular